Su Young Kim
- Hepatology top 5%
- Otorhinolaryngology top 5%
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 6
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
- Advanced Breast Cancer Therapies 2
- Oncology top 10%
-
- Chronic Lymphocytic Leukemia Research 5
-
- Cancer-related gene regulation 2
-
- Pharmacological Effects of Natural Compounds 2
-
- Tuberculosis Research and Epidemiology 2
-
- Liver Disease Diagnosis and Treatment 2
Su Young Kim
36 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 110
- Hepatology 162
- Otorhinolaryngology 72
- Pathology and Forensic Medicine 197
- Pulmonary and Respiratory Medicine 330
- Oncology 264
Countries citing papers authored by Su Young Kim
This map shows the geographic impact of Su Young Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Young Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Young Kim more than expected).
Fields of papers citing papers by Su Young Kim
This network shows the impact of papers produced by Su Young Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Young Kim. The network helps show where Su Young Kim may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Su Young Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 9 | |
| 2 | 2023 | 7 | |
| 3 | 2020 | 17 | |
| 4 | 2018 | 3 | |
| 5 | 2016 | 4 | |
| 6 | 2014 | 60 | |
| 7 | 2011 | 5 | |
| 8 | 2011 | 3 | |
| 9 | 2010 | 16 | |
| 10 | 2010 | 33 | |
| 11 | 2009 | 16 | |
| 12 | 2008 | 26 | |
| 13 | Mycobacterium tuberculosis and NontuberculousMycobacteria by PCR Assay | 2007 | 1 |
| 14 | 2007 | 36 | |
| 15 | 2006 | 2 | |
| 16 | 2006 | 20 | |
| 17 | 2005 | 198 | |
| 18 | 2000 | 27 | |
| 19 | 2000 | 53 | |
| 20 | 2000 | 125 |
About Su Young Kim
Su Young Kim is a scholar working on Genetics, Pathology and Forensic Medicine and Toxicology, having authored 36 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Cancer-related gene regulation (2 papers), Pharmacological Effects of Natural Compounds (2 papers), Advanced Breast Cancer Therapies (2 papers), Tuberculosis Research and Epidemiology (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). The work is most often cited by research in Hepatology (162 citations), Otorhinolaryngology (72 citations) and Pathology and Forensic Medicine (197 citations). Su Young Kim has collaborated with scholars based in South Korea, United States and Australia. Frequent co-authors include Won Sang Park, Ja June Jang, Nam Jin Yoo, Jung Young Lee, Min Sun Shin, Kwang Yeop Jahng, Kang-Yeol Yu, Kyung Soo Lee, Joungho Han and Young Hwa Soung. Their work appears in journals such as Journal of Clinical Oncology, Environmental Science & Technology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.